ASCO 2024 Hybrid Group Meetings

Saturday, June 1st

8:00 AM CT (9:00 AM ET) - Dr. John Livingston // Hybrid

• Desmoid and GIST | Associate Professor, Sarcoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center

8:00 AM CT (9:00 AM ET) - Dr. Whitfield Growdon // *Virtual only*

• GYN Cancer | Associate Professor, Gynecologic Oncology, New York University College of Medicine

9:00 AM CT (10:00 AM ET) - Dr. Robert Dreicer // Hybrid

• Solid Tumor | Director of Solid Tumor Oncology within the Division of Hematology / Oncology, University of Virginia School of Medicine

9:00 AM CT (10:00 AM ET) - Dr. Joseph Kim // *Virtual only*

• GU Cancer | Director of the Prostate Cancer Research Program and Urological Cancers, Yale University

10:00 AM CT (11:00 AM ET) - Dr. Igor Puzanov // Hybrid

• Immunotherapy | Melanoma | Director of Early Phase Clinical Trials and Chief of Melanoma, Roswell Park Cancer Institute

10:00 AM CT (11:00 AM ET) - Dr. Jason Luke // Hybrid

• Immunotherapy | Director of the Immunotherapy and Drug Development Center, University of Pittsburgh School of Medicine

11:00 AM CT (12:00 PM ET) Dr. Ravi Vij // Hybrid

• Multiple Myeloma | Founder, MyCancerHaven

11:00 AM CT (12:00 PM ET) Dr. Tanguy Seiwert // Hybrid

• NSCLC/HNSCC | Director of Head and Neck Oncology Disease Group, Johns Hopkins University

12:00 PM CT (1:00 PM ET) - Dr. Konstantin Dragnev // Hybrid

• NSCLC | Associate Director for Clinical Research, Norris Cotton Cancer Center

12:00 PM CT (1:00 PM ET) - Dr. David Sallman // Hybrid

• AML/ MDS | Assistant Member, H. Lee Moffitt Cancer Center & Research Institute Inc.

1:00 PM CT (2:00 PM ET) - Dr. Patrick Forde // Hybrid

• NSCLC | Director, Thoracic Oncology Research Program, Johns Hopkins School of Medicine

1:00 PM CT (2:00 PM ET) - Dr. C Jillian Tsai // Hybrid

• Head and Neck | Lead, Palliative Radiotherapy and Oligometastasis Program, Princess Margaret Cancer Centre

2:00 PM CT (3:00 PM ET) - Dr. Vamsidhar Velcheti // Hybrid

• NSCLC | Director for Thoracic Oncology Program, NYU Langone Hospitals

2:00 PM CT (3:00 PM ET) - Dr. Thomas Marron // Hybrid

• Immunotherapy | Director of the Early Phase Trials Unit, Icahn School of Medicine, Mount Sinai

3:00 PM CT (4:00 PM ET) - Dr. Michael Morse // Hybrid

• GI Cancer | Medical Oncologist, Duke University Health System Inc.

3:00 PM CT (4:00 PM ET) - Dr. Binod Dhakal // Hybrid

• Multiple Myeloma | Associate Professor of Medicine, Medical College Of Wisconsin

4:00 PM CT (5:00 PM ET) - Dr. Matthew Frigault // Hybrid

• CAR-Ts | Director of Cellular Therapy Service, Massachusetts General Hospital

4:00 PM CT (5:00 PM ET) - Piro Lito // Hybrid

• NSCLC/KRAS | Medical Oncologist, Memorial Sloan Kettering Cancer Center

Sunday, June 2nd

8:00 AM CT (9:00 AM ET) - Ashwin Kishtagari // Hybrid

• MPN (Myelofibrosis, PV, ET), AML/MDS | Assistant Professor of Medicine, Vanderbilt University

8:00 AM CT (9:00 AM ET) - Dr. Barbara Burtness // Hybrid

• Neck and Sarcoma | Chief Translational Research Officer, Yale University School Of Medicine

9:00 AM CT (10:00 AM ET) - Dr. Ran Reshef // Hybrid

• CAR-Ts and Transplants | Professor of Medicine, Columbia University Medical Center

9:00 AM CT (10:00 AM ET) - Dr. Timothy Yap // Hybrid

• DDR | Medical Director, The University of Texas M. D. Anderson Cancer Center Inc.

10:00 AM CT (11:00 AM ET) - Dr. Joshua Sabari // Hybrid

• Lung and NSCLC | Assistant Professor Dept of Medicine, Medical Oncology, NYU Langone Health System

10:00 AM CT (11:00 AM ET) - Dr. Sanjay Aneja // Hybrid

• Radiopharmaceuticals | Assistant Professor of Therapeutic Radiology, Yale University School Of Medicine

11:00 AM CT (12:00 PM ET) - David Aggen // Hybrid

• GU/ Bladder | Genitourinary Oncologist, Memorial Sloan Kettering Cancer Center

11:00 AM CT (12:00 PM ET) - Dr. Namrata Vijayvergia // Hybrid

• Assistant Chief of Gastrointestinal Medical Oncology, Fox Chase Cancer Center Medical Group Inc.

12:00 PM CT (1:00 PM ET) - Dr. Gary Steinberg // Hybrid

• Bladder Cancer | Professor of Urology, Rush University Medical Center

12:00 PM CT (1:00 PM ET) - Dr. Amod Sarnaik // Hybrid

• Melanoma | Associate Professor, H. Lee Moffitt Cancer Center & Research Institute

1:00 PM CT (2:00 PM ET) - Dr. Jared Weiss // Hybrid

• Head and Neck | Section Chief of Thoracic and Head/Neck Oncology, University of North Carolina, Chapel Hill School of Medicine

1:00 PM CT (2:00 PM ET) - Dr. Michael Birrer // Hybrid

• GYN Cancer | Vice Chancellor, The Winthrop P. Rockefeller Cancer Institute, University Of Arkansas Winthrop Rockefeller Institute

2:00 PM CT (3:00 PM ET) - Dr. James Smithy // Hybrid

• Melanoma | Medical Oncologist, Memorial Sloan Kettering Cancer Center

2:00 PM CT (3:00 PM ET) - Dr. Kevin Kalinsky // Hybrid

• Breast Cancer | Director, Glenn Family Breast Center, Winship Cancer Institute of Emory University

3:00 PM CT (4:00 PM ET) - Dr. Rodabe Amaria // Hybrid

• Melanoma - TILs and NRAS | Associate Professor, Department of Melanoma Oncology, The University of Texas M. D. Anderson Cancer Center

3:00 PM CT (4:00 PM ET) - Dr. Jong Chul Park // Hybrid

• HNSCC | Assistant Professor of Medicine, Harvard Medical School

4:00 PM CT (5:00 PM ET) - Dr. Douglas Tremblay // *Virtual only*

• MPN (Myelofibrosis, PV, ET) | Physician and Assistant Professor, Mount Sinai Health System Inc

4:00 PM CT (5:00 PM ET) - Dr. Bently Doonan // Hybrid

• Melanoma | Oncologist, University of Florida

Monday, June 3rd

9:00 AM CT (10:00 PM ET) - Dr. Jae Park // *Virtual only*

• Cell Therapy | Attending Physician, Memorial Sloan Kettering Cancer Center

9:00 AM CT (10:00 PM ET) - Dr. Arvind Dasari // *Virtual only*

• GI Cancer | Associate Professor, The University of Texas M. D. Anderson Cancer Center

10:00 AM CT (11:00 AM ET) - Dr. Giancarlo Moscol // Hybrid

• Breast Cancer | Assistant Professor, The University of Texas M. D. Anderson Cancer Center

11:00 AM CT (12:00 PM ET) - Dr. Hyunseok Kang // Hybrid

• Head and Neck | Associate Professor, The University of California, San Francisco

12:00 PM CT (1:00 PM ET) - Dr. Scott Tagawa // Hybrid

• GU Cancer | Professor of Medicine & Urology / Attending Physician, Weill Cornell Medical College, New York

12:00 PM CT (1:00 PM ET) - Dr. Ryan Corcoran // Hybrid

• GI Cancer and KRAS | Scientific Director of the Termeer Center for Targeted Therapies, Massachusetts General Hospital

1:00 PM CT (2:00 PM ET) - Dr. Neil Iyengar // Hybrid

• Breast Cancer | Breast Oncologist, Memorial Sloan Kettering Cancer Center

1:00 PM CT (2:00 PM ET) - Dr. Paul Nathan // Hybrid

• Melanoma | Consultant Oncologist, Mount Vernon Cancer Centre

2:00 PM CT (3:00 PM ET) - Dr. Premal Thaker // Hybrid

• GYN Cancer | Associate Professor in Gynecologic Oncology, Washington University, St. Louis

2:00 PM CT (3:00 PM ET) - Dr. Dr. Chris Vaklavas // Hybrid

• Breast Cancer | Associate Professor, Huntsman Cancer Institute, The University of Utah

Tuesday, June 4rth

8:00 AM CT (9:00 AM ET) - Dr. Roger Greenberg // *Virtual only*

• DDR Therapeutics | Professor and Director of the Penn Center for Genome Integrity, Perelman School of Medicine, the University of Pennsylvania